Comparative Effectiveness of eConsent: Systematic Review
Journal of Medical Internet Research · 2023
DOI: 10.2196/43883 ↗At a glance
Systematische Übersicht in Journal of Medical Internet Research, 2023. Written by Edwin Cohen and 4 co-authors. Institution: AstraZeneca BV, The Hague, Netherlands. Major MEDLINE topics: Data Accuracy, Digital Technology. Cited 29 times so far (Crossref); 69 references. The full text is freely available in PubMed Central.
Abstract (original language)
Background
Providing informed consent means agreeing to participate in a clinical trial and having understood what is involved. Flawed informed consent processes, including missing dates and signatures, are common regulatory audit findings. Electronic consent (eConsent) uses digital technologies to enable the consenting process. It aims to improve participant comprehension and engagement with study information and to address data quality concerns.
Objective
This systematic literature review aimed to assess the effectiveness of eConsent in terms of patient comprehension, acceptability, usability, and study enrollment and retention rates, as well as the effects of eConsent on the time patients took to perform the consenting process (“cycle time”) and on-site workload in comparison with traditional paper-based consenting.
Methods
The systematic review was conducted and reported in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Ovid Embase and Ovid MEDLINE were systematically searched for publications reporting original, comparative data on the effectiveness of eConsent in terms of patient comprehension, acceptability, usability, enrollment and retention rates, cycle time, and site workload. The methodological validity of the studies that compared outcomes for comprehension, acceptability, and usability across paper consent and eConsent was assessed. Study methodologies were categorized as having “high” validity if comprehensive assessments were performed using established instruments.
Results
Overall, 37 publications describing 35 studies (13,281 participants) were included. All studies comparing eConsenting and paper-based consenting for comprehension (20/35, 57% of the studies; 10 with “high” validity), acceptability (8/35, 23% of the studies; 1 with “high” validity), and usability (5/35, 14% of the studies; 1 with “high” validity) reported significantly better results with eConsent, better results but without significance testing, or no significant differences in overall results. None of the studies reported better results with paper than with eConsent. Among the “high” validity studies, 6 studies on comprehension reported significantly better understanding of at least some concepts, the study on acceptability reported statistically significant higher satisfaction scores, and the study on usability reported statistically significant higher usability scores with eConsent than with paper (P
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- AstraZeneca BV, The Hague, Netherlands.
- Signant Health, London, United Kingdom.
- Oxford PharmaGenesis, Oxford, United Kingdom.
- AstraZeneca, Gothenburg, Sweden.
- Nottingham Trent University, Nottingham, United Kingdom.
ORCID profiles: Edwin Cohen, Bill Byrom, Anja Becher, Magnus Jörntén-Karlsson, Andrew K Mackenzie
Cite
APA
Cohen, E., Byrom, B., Becher, A., Jörntén-Karlsson, M., & Mackenzie, A. K. (2023). Comparative Effectiveness of eConsent: Systematic Review. Journal of Medical Internet Research. https://doi.org/10.2196/43883
Vancouver
Cohen E, Byrom B, Becher A, Jörntén-Karlsson M, Mackenzie AK. Comparative Effectiveness of eConsent: Systematic Review. Journal of Medical Internet Research. 2023. doi:10.2196/43883
BibTeX
@article{Cohen2023,
author = {Cohen, Edwin and Byrom, Bill and Becher, Anja and Jörntén-Karlsson, Magnus and Mackenzie, Andrew K},
title = {Comparative Effectiveness of eConsent: Systematic Review},
journal = {Journal of Medical Internet Research},
year = {2023},
doi = {10.2196/43883}
}
EUVIMED